Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Bin Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4843-2529; OpenAlex author ID A5100392842. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper

Papers 3

  1. MAL2 interacts with IQGAP1 to promote pancreatic cancer progression by increasing ERK1/2 phosphorylation. Co-author DOI 10.1016/j.bbrc.2021.02.146↗
  2. The CDK4/6 inhibitor PD0332991 stabilizes FBP1 by repressing MAGED1 expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biocel.2020.105859↗
  3. MIB1 Upregulates IQGAP1 and Promotes Pancreatic Cancer Progression by inducing ST7 Degradation First author DOI 10.21203/rs.3.rs-76668/v1↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiang Chao Cheng · 2 shared papers, 2020–2021 · strength 0.35
  2. Xin Jin · 2 shared papers, 2020 · strength 0.32
  3. Tao Liu · 1 shared paper, 2021 · strength 0.19
  4. Tao Liu · 1 shared paper, 2020 · strength 0.16
  5. Kun Zhang · 1 shared paper, 2020 · strength 0.16
  6. Dan Li · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.